Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Rottendorf Inks Five Development and Mfg. Contracts | Contract Pharma

What are you searching for?

Sign in
Breaking News

Rottendorf Inks Five Development and Mfg. Contracts

Employs Total Process Ownership business model

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Rottendorf Pharmaceuticals has recently signed three formulation development projects and two commercial transfer projects with several top five Pharma/Biopharma companies. Additional details were not disclosed.

“The new projects signed in the last quarter reflect the industry’s positive response to our business model and our commitment to Total Process Ownership (TPO),” said Rottendorf Pharmaceuticals chief executive officer, Gordon Haines. “TPO relies on open communication and exchange of ideas with our pharma partners and draws on 85 years of formulation development and manufacturing experience to recommend process optimizations to ultimately produce a better end product.”

Under TPO, Rottendorf assumes a high degree of process responsibility and ownership aimed at reducing management oversight for the client; reduced complexity and supply chain improvements.

Mr. Haines added, “We are owned by a charitable foundation, which allows us to focus more on long-term success of our business and the goals of our customers, rather than needing to satisfy shareholders on a quarter-by-quarter basis.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics